Literature DB >> 16387988

Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis.

Christopher A Wall1, Teresa A Rummans, Allen J Aksamit, Lois E Krahn, V Shane Pankratz.   

Abstract

This study characterizes the type and timing of psychiatric manifestations in sporadic Creutzfeldt-Jakob disease (sCJD). Historically, sCJD has been characterized by prominent neurological symptoms, while the variant form (vCJD) is described as primarily psychiatric in presentation and course: A retrospective review of 126 sCJD patients evaluated at the Mayo Clinic from 1976-2001 was conducted. Cases were reviewed for symptoms of depression, anxiety, psychosis, behavior dyscontrol, sleep disturbances, and neurological signs during the disease course. Eighty percent of the cases demonstrated psychiatric symptoms within the first 100 days of illness, with 26% occurring at presentation. The most commonly reported symptoms in this population included sleep disturbances, psychotic symptoms, and depression. Psychiatric manifestations are an early and prominent feature of sporadic CJD, often occurring prior to formal diagnosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16387988     DOI: 10.1176/jnp.17.4.489

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  18 in total

1.  Autoimmune limbic encephalitis presenting as relapsing psychosis.

Authors:  Sarah A Hopkins; Kuven K Moodley; Dennis Chan
Journal:  BMJ Case Rep       Date:  2013-08-30

Review 2.  Neuropsychiatric Aspects of Infectious Diseases: An Update.

Authors:  Sahil Munjal; Stephen J Ferrando; Zachary Freyberg
Journal:  Crit Care Clin       Date:  2017-07       Impact factor: 3.598

Review 3.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

4.  The Creutzfeldt-Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression.

Authors:  O S Cohen; I Prohovnik; A D Korczyn; L Ephraty; Z Nitsan; R Tsabari; S Appel; H Rosenmann; E Kahana; J Chapman
Journal:  Acta Neurol Scand       Date:  2011-02-08       Impact factor: 3.209

5.  Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice.

Authors:  Danielle Beckman; Luis E Santos; Tatiana A Americo; Jose H Ledo; Fernando G de Mello; Rafael Linden
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

6.  Severe depression masquerading as Creutzfeldt-Jakob disease.

Authors:  Elizabeth Shiner; Lauren Taylor; Adith Mohan; Shaun Watson; Perminder Singh Sachdev
Journal:  BMJ Case Rep       Date:  2014-04-19

7.  Sleep Pathology in Creutzfeldt-Jakob Disease.

Authors:  Peter Kang; Gabriela S de Bruin; Leo H Wang; Beth A Ward; Beau M Ances; Miranda M Lim; Robert C Bucelli
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

8.  Sporadic Creutzfeldt-Jakob disease (sCJD) with asymmetric findings.

Authors:  Madhuri Khilari; Sunitha Vellathussery Chakkalakkoombil; Vaibhav Wadwekar; Pradeep Pankajakshan Nair
Journal:  BMJ Case Rep       Date:  2014-03-24

9.  Clinical and MRI evaluation of anxiety as the first symptom of sporadic Creutzfeldt-Jakob disease: A case report.

Authors:  Weibo Liu; Yunrong Lu; Guodong Zhong; Biao Jiang; Zhijie Pan
Journal:  Exp Ther Med       Date:  2016-02-01       Impact factor: 2.447

10.  Premortem diagnosis of pathologically confirmed sporadic Creutzfeldt-Jakob disease.

Authors:  Elina T Ziukelis; Vasu Keshav Sharma; James J Gome
Journal:  Clin Case Rep       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.